Bevatas 400 mg injection
  1. Home
  2. Pharma Products
  3. Intas Pharmaceuticals Ltd
  4. Bevatas 400 mg injection

Bevatas 400 mg injection

Bevatas 400 mg Injection contains bevacizumab 400 mg and is a targeted anticancer medicine. It is used for several advanced cancers, including colorectal, non-small-cell lung, kidney, ovarian, and cervical cancers. The medicine is administered as an intravenous infusion by a qualified healthcare professional.

BUY NOW

Category

Bevacizumab is a monoclonal antibody that targets VEGF-A and inhibits the formation of new blood vessels that tumors need for growth. It is commonly used in combination with chemotherapy or other cancer treatments according to the specific cancer and treatment protocol. Blood pressure, urine protein, kidney function, and other clinical parameters may need monitoring because treatment can cause hypertension, proteinuria, bleeding, or other serious reactions. The dosage and infusion schedule are determined by the treating oncologist according to the cancer type and individual treatment plan.

Technical Specification

Specification Details
Active Ingredient Bevacizumab
Strength 400 mg/16 mL
Dosage Form Solution for Infusion
Route of Administration Intravenous Infusion
Pack Size 1 vial of 16 mL
Manufacturer Intas Pharmaceuticals Ltd

Product Also Known As

Bevatas 400mg Injection, Bevatas 400 mg Injection, Bevatas 400 Solution for Infusion, Bevacizumab 400mg Injection, Bevacizumab 400 mg Injection, Bevacizumab 400mg Infusion, Bevacizumab 400mg Oncology Injection